The Madras High Court dismissed an appeal challenging the rejection of a patent application for AI-integrated persona augmentation. The Court ruled that the invention lacked sufficient technical detail, inventive step, and patent-eligible subject matter under the Patents Act. It upheld the Controller’s decision, emphasizing the absence of tangible technical effects and clear disclosure requirements.
Read more about Madras High Court Affirms Rejection of AI-Integrated Persona PatentCategory: Patents
Clarifying Patentability of Plant Treatment Methods under Section 3(h) and 3(i)
The Delhi High Court, in Syngenta Crop Protection AG vs. Assistant Controller of Patents and Designs, examined the rejection of an Indian patent application under Section 3(h) of the Patents Act. The Court ruled that plant treatment methods are distinct from agricultural processes, referring to the 2003 amendment to Section 3(i), and remanded the case for fresh examination with amended claims.
Read more about Clarifying Patentability of Plant Treatment Methods under Section 3(h) and 3(i)The Draft guidelines for AYUSH Patent Applications
The Intellectual Property (IP) Office has issued Draft Guidelines for the processing of patent applications related to AYUSH systems and related inventions. These guidelines aim to streamline the evaluation process of patent applications concerning Ayurveda, Yoga & Naturopathy, Unani, Siddha, Sowa-Rigpa, and Homeopathy.
Read more about The Draft guidelines for AYUSH Patent ApplicationsCourt clarifies distinction between business methods and technical inventions in section 3(k) related case
The Delhi High Court set aside the Indian Patent Office’s rejection of Comviva Technologies Limited’s patent application under Section 3(k) of the Patents Act, 1970. The Court recognized that the invention provided a technical advancement in securing electronic payment transactions. It directed the Patent Office to proceed with granting the patent, subject to any further objections under the law.
Read more about Court clarifies distinction between business methods and technical inventions in section 3(k) related caseEvaluation of Technical Advancement and Compliance with CRI Guidelines under Indian Patent Law
The Madras High Court allowed Idemia Identity & Security France’s appeal, setting aside a refusal order under Section 3(k) for a cryptography patent. The Court ruled the order as a non-speaking one and in violation of natural justice. It directed fresh consideration of the matter, emphasizing technical contributions and adherence to CRI and European guidelines.
Read more about Evaluation of Technical Advancement and Compliance with CRI Guidelines under Indian Patent LawCourt refuses interim injunction based on Patent Prosecution History
The Delhi High Court refused an interim injunction in a patent dispute over a fuel cap, citing ambiguous claims and prosecution history. The judgment highlights the need for precise claim drafting and careful interpretation in patent litigation.
Read more about Court refuses interim injunction based on Patent Prosecution HistoryIndian Patent and Design Statistics 2024 (December 13th to 20th)
This weekly report analyses Indian patent and design statistics for December 13th to 20th, 2024, highlighting key data trends and city-wise breakdowns. It offers insights into patent publications, grants, examinations, and industrial design registrations, compiled by BananaIP’s expert team.
Read more about Indian Patent and Design Statistics 2024 (December 13th to 20th)Madras HC Overrules Procedural Rejection in France Telecom’s Patent Case
The Madras High Court allowed France Telecom’s writ petition, setting aside the procedural rejection of its patent application examination request. The judgment clarifies the treatment of agent errors under Indian patent law and upholds procedural fairness.
Read more about Madras HC Overrules Procedural Rejection in France Telecom’s Patent CaseRevisiting Novartis versus Natco – Cancer drugs, divisional applications and patent validity
The Delhi High Court upheld the validity of Novartis’s Ceritinib patent against Natco’s challenge, addressing divisional application issues and allegations of suppression. The injunction against Natco remains in force, reinforcing the enforceability of Novartis’s patent rights.
Read more about Revisiting Novartis versus Natco – Cancer drugs, divisional applications and patent validityMadras High Court Overturns Patent Refusal under section 3(d), Reiterates Importance of Reasoned Orders and Natural Justice
The Madras High Court set aside a patent refusal under section 3d, citing lack of procedural fairness and insufficient reasoning. The Court directed reconsideration, underscoring the necessity of reasoned orders and respect for principles of natural justice in patent proceedings.
Read more about Madras High Court Overturns Patent Refusal under section 3(d), Reiterates Importance of Reasoned Orders and Natural Justice